Phio Pharmaceuticals Announces FDA Clearance to Initiate Clinical Trial of PH-762 for Treatment of Skin Carcinomas

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed…

USDA honors Texas A&M’s Patrick J. Stover, director of Institute for Advancing Health Through Agricultur

Patrick J. Stover, Ph.D., director of the Texas A&M Institute for Advancing Health through Agriculture (IHA), has been named…

MediBeacon Inc. Appoints Dr. Steve Miller as Chief Medical Officer

MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced the…

Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023

 Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the presentation of results from two…

Welltower Announces Proposed Private Placement of $750 Million of Exchangeable Senior Notes

 Welltower® Inc. (NYSE: WELL) (“Welltower” or the “Company”) announced today that its operating company, Welltower OP LLC…

Hummingbird Bioscience to Present Preclinical Proof of Concept for Potentially First-In-Class Antibody Targeting Autoimmune Diseases

Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases,…

Sun Life U.S. appoints Miles Varn, M.D., as Chief Medical Officer

Sun Life U.S. today announced that Miles Varn, M.D., has been named chief medical officer (CMO), a…

Dermabrasion And Microneedling Market to Reach $684.4 Million, Globally, by 2031 at 5.1% CAGR: Allied Market Research

Allied Market Research published a report, titled, “Dermabrasion and Microneedling Market By Procedure (Dermabrasion, Microneedling), By Gender…

Nuance Pharma Announces Dosing of First Patient in ENHANCE – China Phase III Trial for Chronic Obstructive Pulmonary Disease (“COPD”)

Nuance Pharma (“the Company”) announces dosing of first patient in the ENHANCE – China Phase III Trial…

Sunshine Health to Serve as Children’s Day Featured Partner

 Sunshine Health, as well as Children’s Medical Services Health Planoperated by Sunshine Health on behalf of the…